Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBRA-light vs COBRA (BeSt) in early rheumatoid arthritis
2007-002976-32Phase 4Active
- Sponsor
- TI Pharma
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone, methotrexate and 5-aminosalicylic acid + sulphasalazine in rheumatoid arthritis (RA) (2 arms), sponsored by TI Pharma. Started Aug 2007; status: active.
02
Drugs
prednisonemethotrexate5-aminosalicylic acid + sulphasalazine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-002976-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002976-32.